First Page | Document Content | |
---|---|---|
Organochlorides Lactams Hypnotics Sanofi Intermezzo Zolpidem Eszopiclone Zopiclone Insomnia Chemistry Nonbenzodiazepines Organic chemistry | FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 187,93 KBShare Document on Facebook |